Avestar Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,495
| Closed | -$296K | – | 445 |
|
|
2024
Q2 | $296K | Buy |
2,495
+608
| +32% | +$72.2K | 0.03% | 304 |
|
|
2024
Q1 | $201K | Buy |
+1,887
| New | +$201K | 0.02% | 397 |
|
|
2022
Q3 | – | Sell |
-307
| Closed | -$44K | – | 268 |
|
|
2022
Q2 | $44K | Buy |
+307
| New | +$44K | 0.01% | 248 |
|
|
2022
Q1 | – | Sell |
-5,438
| Closed | -$1.38M | – | 384 |
|
|
2021
Q4 | $1.38M | Sell |
5,438
-844
| -13% | -$214K | 0.17% | 86 |
|
|
2021
Q3 | $2.42M | Sell |
6,282
-3,421
| -35% | -$1.32M | 0.31% | 45 |
|
|
2021
Q2 | $2.28M | Buy |
9,703
+184
| +2% | +$43.2K | 0.31% | 53 |
|
|
2021
Q1 | $1.7M | Buy |
9,519
+1,238
| +15% | +$221K | 0.38% | 47 |
|
|
2020
Q4 | $865K | Buy |
8,281
+3,340
| +68% | +$349K | 0.24% | 79 |
|
|
2020
Q3 | $347K | Buy |
+4,941
| New | +$347K | 0.11% | 146 |
|